denifanstat
AssetAlso TVB-2640, ASC40
Inhibits fatty acid synthase, reducing de novo fatty acid synthesis.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Acne vulgaris
Phase 3, globenewswire.com, 9 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners2
- Evidence for its targets2
- Competitors1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.